Community Health Systems vs Surgery Partners
CYH and SGRY side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CYH and SGRY compare
Surgery Partners is the larger company, worth 9.0 times as much as Community Health Systems ($3.0B against $338M).
Surgery Partners grew revenue faster over the last twelve months (4.0% versus −7.8% for Community Health Systems).
Community Health Systems keeps more of each dollar of sales as profit, with a net margin of 0.31% compared with −2.6% at Surgery Partners.
Community Health Systems scores higher on the StockData Score (8 against 6 for Surgery Partners), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CYH | SGRY |
|---|---|---|
| Size and price | ||
| Market cap | $338M | $3.0B |
| Share price | $2.40 | $23.21 |
| Change, 1 year | −43.0% | 2.0% |
| Change, 5 years | −83.3% | −53.7% |
| Beta (5Y) | 1.69 | 1.64 |
| Employees | 57K | 16K |
| StockData Score | ||
| Total score | 8 (better) | 6 |
| Valuation score | 3 (better) | 2 |
| Growth score | 2 (better) | 0 |
| Performance score | 2 | 2 |
| Health score | 1 | 2 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 9.2× | – |
| P/S | 0.0× (better) | 0.9× |
| P/B | – | 1.8× |
| EV/EBITDA | 5.9× (better) | 14.3× |
| P/FCF | – | 16.2× |
| PEG | 0.08 | – |
| FCF yield | −36.0% | 6.2% (better) |
| Fair value | – | $21.97 |
| Margin of safety | – | −5.7% |
| Growth | ||
| Revenue growth (TTM) | −7.8% | 4.0% (better) |
| Revenue growth, 5Y average | 1.2% | 12.2% (better) |
| Net income growth (TTM) | −89.1% | – |
| EPS growth (TTM) | −89.3% | – |
| EPS growth, 5Y average | −3.0% | – |
| Profitability | ||
| Gross margin | 85.5% | – |
| Operating margin | 10.9% | 11.4% (better) |
| Net margin | 0.31% (better) | −2.6% |
| FCF margin | −1.0% | 5.6% (better) |
| Return on equity | – | −5.2% |
| Return on invested capital | 7.5% (better) | 5.9% |
| Financial health | ||
| Debt / equity | – | 2.25 |
| Net debt / EBITDA | 5.54 (better) | 6.30 |
| Current ratio | 1.48 | 1.95 (better) |
| Altman Z-score | 1.00 (better) | 0.87 |
| Piotroski F-score | 8 (better) | 4 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 82.7% | 121% |
| Held by insiders | 9.0% | 85.9% |
| Insider net buying, 12 months | −$118K (better) | −$979K |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 9.6% | 77.9% |
Go deeper
- CYH stock overview
- CYH income statement
- CYH valuation and score
- SGRY stock overview
- SGRY income statement
- SGRY valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.